Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collag… Read more
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) - Net Assets
Latest net assets as of March 2025: $-4.46 Million USD
Based on the latest financial reports, Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) has net assets worth $-4.46 Million USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.75 Million) and total liabilities ($6.20 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-4.46 Million |
| % of Total Assets | -255.57% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares - Net Assets Trend (2021–2024)
This chart illustrates how Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (2021–2024)
The table below shows the annual net assets of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-4.46 Million | -53.93% |
| 2023-12-31 | $-2.90 Million | -62.92% |
| 2022-12-31 | $-1.78 Million | -160.17% |
| 2021-12-31 | $-683.52K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 377460600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $24.20K | % |
| Other Comprehensive Income | $-1.59K | % |
| Other Components | $78.72K | % |
| Total Equity | $-4.46 Million | 100.00% |
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Competitors by Market Cap
The table below lists competitors of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Future Lifestyle Fashions Limited
NSE:FLFL
|
$2.50 Million |
|
ORAPI S.A. INH. EO 1
F:O4P
|
$2.51 Million |
|
AMERICAN EXPRESS - Dusseldorf Stock Exchang
DU:AEC1
|
$2.51 Million |
|
HYDROFARM HLD. GRP -0001
F:5TUA
|
$2.51 Million |
|
Oceancash Pacific Bhd
KLSE:0049
|
$2.50 Million |
|
NORFOLK SOUTHERN
MU:NFS
|
$2.50 Million |
|
Accuracy Shipping Limited
NSE:ACCURACY
|
$2.50 Million |
|
TERADYNE
MU:TEY
|
$2.50 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -2,897,284 to -4,459,722, a change of -1,562,438.
- Net loss of 1,560,535 reduced equity.
- Other comprehensive income decreased equity by 1,903.
- Other factors decreased equity by 0.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.56 Million | -34.99% |
| Other Comprehensive Income | $-1.90K | -0.04% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $-0.03 | $0.34 | x |
| 2022-12-31 | $-0.09 | $0.34 | x |
| 2023-12-31 | $-0.13 | $0.34 | x |
| 2024-12-31 | $-0.21 | $0.34 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cuprina Holdings (Cayman) Limited Class A Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3229.52%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | -888.29% | 0.06x | 0.00x | $-451.33K |
| 2022 | 0.00% | -1933.81% | 0.04x | 0.00x | $-916.69K |
| 2023 | 0.00% | -1110.97% | 0.06x | 0.00x | $-829.83K |
| 2024 | 0.00% | -3229.52% | 0.03x | 0.00x | $-1.11 Million |
Industry Comparison
This section compares Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) | $-4.46 Million | 0.00% | N/A | $2.50 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |